97 related articles for article (PubMed ID: 9787693)
1. Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation.
Ferraris JR; Sorroche P; Legal S; Oyhamburu J; Brandi P; Pasqualini T
J Pediatr; 1998 Oct; 133(4):533-6. PubMed ID: 9787693
[TBL] [Abstract][Full Text] [Related]
2. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
Ferraris JR; Pasqualini T; Legal S; Sorroche P; Galich AM; Pennisi P; Domene H; Jasper H
Pediatr Nephrol; 2000 Jul; 14(7):682-8. PubMed ID: 10912543
[TBL] [Abstract][Full Text] [Related]
3. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich AM; Jasper H;
Pediatr Nephrol; 2007 May; 22(5):734-41. PubMed ID: 17294225
[TBL] [Abstract][Full Text] [Related]
4. Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation.
Ferraris JR; Fainstein Day P; Gutman R; Granillo E; Ramirez J; Ruiz S; Pasqualini T
J Pediatr; 1992 Nov; 121(5 Pt 1):809-13. PubMed ID: 1432436
[TBL] [Abstract][Full Text] [Related]
5. Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation.
Ferraris JR; Pennisi P; Pasqualini T; Jasper H
Pediatr Nephrol; 1997 Jun; 11(3):322-4. PubMed ID: 9203181
[TBL] [Abstract][Full Text] [Related]
6. Therapy with a new glucocorticoid: effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.
Ferraris JR; Pasqualini T
J Rheumatol Suppl; 1993 Apr; 37():43-6. PubMed ID: 8501752
[TBL] [Abstract][Full Text] [Related]
7. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
Elli A; Rivolta R; Palazzi P; Mascaretti L; Puglisi G; Parenti M; Sioli V; Di Palo FQ
Transplant Proc; 1990 Aug; 22(4):1689-90. PubMed ID: 2202126
[No Abstract] [Full Text] [Related]
8. A randomized study comparing deflazacort and prednisone in heart transplant patients.
Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
[TBL] [Abstract][Full Text] [Related]
9. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
10. Relation of cyclosporine blood levels to adverse effects on lipoproteins.
Kuster GM; Drexel H; Bleisch JA; Rentsch K; Pei P; Binswanger U; Amann FW
Transplantation; 1994 May; 57(10):1479-83. PubMed ID: 8197611
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
Singh A; Tejani A
Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin reduces serum cholesterol and low density lipoprotein concentrations following pancreas transplantation.
al'Halawani MH; Larsen JL; Miller S; Frisbie K; Taylor RJ; Stratta RJ
Transplantation; 1994 Dec; 58(11):1204-9. PubMed ID: 7992364
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation--immunosuppressive activity and side effects.
Elli A; Rivolta R; Di Palo FQ; Parenti M; Vergallo G; Palazzi P; Zafiropulu S; Abelli P; Zanussi C
Transplantation; 1993 Jan; 55(1):209-12. PubMed ID: 8420051
[No Abstract] [Full Text] [Related]
15. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children.
Kwiterovich PO; Vining EP; Pyzik P; Skolasky R; Freeman JM
JAMA; 2003 Aug; 290(7):912-20. PubMed ID: 12928468
[TBL] [Abstract][Full Text] [Related]
16. A study on strategies for improving growth and body composition after renal transplantation.
Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich A; Coccia P; Ghezzi L; Ferraris V; Karabatas L; Guida C; Jasper H
Pediatr Nephrol; 2010 Apr; 25(4):753-62. PubMed ID: 20151158
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with deflazacort, a new synthetic steroid with fewer undesirable side effects, in heart transplant patients.
Arizón JM; Anguita M; Vallés F; Montero A; Sancho M; López-Rubio F; Latre JM; Calleja F; Casares J; Román M
J Heart Lung Transplant; 1993; 12(3):445-8; discussion 448-9. PubMed ID: 8329416
[TBL] [Abstract][Full Text] [Related]
19. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
[TBL] [Abstract][Full Text] [Related]
20. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
